SYNGENE INTERNATIONAL LIMITED UNIT IV

Business Type: Manufacturer / Contract Research and Manufacturing Organization (CRAMS)

Description:

Syngene International Limited is a prominent integrated research, development, and manufacturing organization based in India. It provides comprehensive scientific services spanning the entire drug discovery and development lifecycle, from early-stage research to commercial production. Unit IV signifies one of its operational facilities, which typically comprises advanced laboratories, research and development centers, and manufacturing plants. As a leading Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO), Syngene is actively involved in the production of drug substances, biologics, and other pharmaceutical intermediates for its global clients. Therefore, it operates as a manufacturer with significant factory capabilities. Its service offerings include discovery chemistry, discovery biology, small molecule development, biologics development, and manufacturing.

SYNGENE INTERNATIONAL LIMITED UNIT IV, located in India, is a Contract Research, Development, and Manufacturing Organization (CRDMO). It primarily offers services and solutions to pharmaceutical, biotechnology, nutrition, animal health, and consumer goods companies rather than producing or selling proprietary end-products.

The services and solutions provided include:

Discovery Services:

Target identification and validation

Lead generation and optimization

Medicinal chemistry

In vitro and in vivo pharmacology studies

Structural biology

ADME/DMPK (Absorption, Distribution, Metabolism, Excretion, Pharmacokinetics) studies

Development Services:

Preclinical development programs

Toxicology studies

Bioanalytical services

Clinical development support

Manufacturing Services:

Small molecule manufacturing for clinical trials (API and intermediates)

Biologics manufacturing (e.g., monoclonal antibodies, recombinant proteins)

Formulation development

Analytical development and quality control

Integrated Drug Discovery and Development Solutions:

Comprehensive programs from target identification through to Investigational New Drug (IND) submission

Process development and scale-up for drug candidates